|Articles|August 10, 2022
- Pharmaceutical Executive-08-01-2022
- Volume 42
- Issue 8
Pharmaceutical Executive, August 2022 Issue (PDF)
Advertisement
Articles in this issue
about 4 years ago
The Silver Lining Of Innovation in Genetic Medicineabout 4 years ago
Navigating the Financial Meltdown for Biopharmaabout 4 years ago
The Potential of Proteomicsabout 4 years ago
Getting ‘Personal’ With Vaccine Developmentabout 4 years ago
A World of Opportunityabout 4 years ago
Has Biotech Bottomed Out—and is Recent Recovery Sustainable?Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
3
What's Next for Compounded Peptides: Q&A with Nate Hill
4
Pharmaceutical Executive Daily: FDA Approves Zanvastro
5